Literature DB >> 23307449

Severe CMV complication following maintenance therapy with rituximab.

Lenaïg Le Clech1, Jean-Christophe Ianotto, Isabelle Quintin-Roue, Adrian Tempescul.   

Abstract

Cytomegalovirus (CMV) encephalitis is a rare infection that immunodeficient patients, mainly where HIV-positive, may suffer from. Several cases were described when complications with the treatment with monoclonal antibodies, like rituximab, for malignant lymphomas. We will describe here the case of a patient, who has developed CMV gastritis, then CMV encephalitis after the treatment of a CLL with a chemotherapy and maintenance therapy with rituximab.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23307449      PMCID: PMC3603828          DOI: 10.1136/bcr-2012-006672

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder.

Authors:  F Suzan; M Ammor; V Ribrag
Journal:  N Engl J Med       Date:  2001-09-27       Impact factor: 91.245

Review 2.  Does rituximab increase the incidence of infectious complications? A narrative review.

Authors:  Theodoros Kelesidis; George Daikos; Dimitrios Boumpas; Sotirios Tsiodras
Journal:  Int J Infect Dis       Date:  2010-11-11       Impact factor: 3.623

Review 3.  Rituximab-associated infections.

Authors:  Juan C Gea-Banacloche
Journal:  Semin Hematol       Date:  2010-04       Impact factor: 3.851

Review 4.  Definitions of cytomegalovirus infection and disease in transplant recipients.

Authors:  Per Ljungman; Paul Griffiths; Carlos Paya
Journal:  Clin Infect Dis       Date:  2002-03-11       Impact factor: 9.079

5.  Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia.

Authors:  Michael J Keating; Susan O'Brien; Maher Albitar; Susan Lerner; William Plunkett; Francis Giles; Michael Andreeff; Jorge Cortes; Stefan Faderl; Deborah Thomas; Charles Koller; William Wierda; Michelle A Detry; Alice Lynn; Hagop Kantarjian
Journal:  J Clin Oncol       Date:  2005-03-14       Impact factor: 44.544

6.  Cytomegalovirus ventriculoencephalitis in a peripheral blood stem cell transplant recipient.

Authors:  Geraldine G Miller; Guy Boivin; J Stephen Dummer; Thomas McConnell; Mark W Becher; Adetola Kassim; Yi-Wei Tang
Journal:  Clin Infect Dis       Date:  2006-01-06       Impact factor: 9.079

Review 7.  Rituximab-related viral infections in lymphoma patients.

Authors:  Sercan Aksoy; Hakan Harputluoglu; Saadettin Kilickap; Didem Sener Dede; Omer Dizdar; Kadri Altundag; Ibrahim Barista
Journal:  Leuk Lymphoma       Date:  2007-07

8.  Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet.

Authors:  Petr Hubacek; Petra Keslova; Renata Formankova; Pavel Pochop; Ondrej Cinek; Miroslav Zajac; Jana Lochmanova; Jan Stary; Petr Sedlacek
Journal:  Pediatr Transplant       Date:  2008-11-01

Review 9.  Regulatory B cells play a key role in immune system balance.

Authors:  Jean-Marie Berthelot; Christophe Jamin; Kahina Amrouche; Benoit Le Goff; Yves Maugars; Pierre Youinou
Journal:  Joint Bone Spine       Date:  2012-07-31       Impact factor: 4.929

  9 in total
  4 in total

Review 1.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

Review 2.  Cytomegalovirus in the neonate: immune correlates of infection and protection.

Authors:  Mark R Schleiss
Journal:  Clin Dev Immunol       Date:  2013-08-19

Review 3.  Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia.

Authors:  Alessandro Allegra; Alessandro Tonacci; Caterina Musolino; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Front Immunol       Date:  2021-10-25       Impact factor: 7.561

4.  Cytomegalovirus infection in patients with malignant lymphomas who have not received hematopoietic stem cell transplantation.

Authors:  Kazuya Sato; Sho Igarashi; Nodoka Tsukada; Junki Inamura; Masayo Yamamoto; Motohiro Shindo; Kentaro Moriichi; Yusuke Mizukami; Mikihiro Fujiya; Yoshihiro Torimoto
Journal:  BMC Cancer       Date:  2022-09-01       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.